- Home
- CRVS vs PKE Comparison
CRVS vs PKE Comparison
Compare CRVS & PKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- PKE
- Stock Information
- Founded
- CRVS 2014
- PKE 1954
- Country
- CRVS United States
- PKE United States
- Employees
- CRVS N/A
- PKE N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- PKE Military/Government/Technical
- Sector
- CRVS Health Care
- PKE Industrials
- Exchange
- CRVS Nasdaq
- PKE Nasdaq
- Market Cap
- CRVS 459.0M
- PKE 378.7M
- IPO Year
- CRVS 2016
- PKE N/A
- Fundamental
- Price
- CRVS $7.00
- PKE $20.62
- Analyst Decision
- CRVS Strong Buy
- PKE
- Analyst Count
- CRVS 3
- PKE 0
- Target Price
- CRVS $13.00
- PKE N/A
- AVG Volume (30 Days)
- CRVS 789.4K
- PKE 135.2K
- Earning Date
- CRVS 11-11-2025
- PKE 10-09-2025
- Dividend Yield
- CRVS N/A
- PKE 2.51%
- EPS Growth
- CRVS N/A
- PKE 4.18
- EPS
- CRVS N/A
- PKE 0.34
- Revenue
- CRVS N/A
- PKE $63,456,000.00
- Revenue This Year
- CRVS N/A
- PKE N/A
- Revenue Next Year
- CRVS N/A
- PKE N/A
- P/E Ratio
- CRVS N/A
- PKE $60.59
- Revenue Growth
- CRVS N/A
- PKE 16.60
- 52 Week Low
- CRVS $2.54
- PKE $11.97
- 52 Week High
- CRVS $10.00
- PKE $21.01
- Technical
- Relative Strength Index (RSI)
- CRVS 58.81
- PKE 62.17
- Support Level
- CRVS $6.65
- PKE $19.51
- Resistance Level
- CRVS $7.39
- PKE $20.75
- Average True Range (ATR)
- CRVS 0.42
- PKE 0.71
- MACD
- CRVS -0.04
- PKE -0.01
- Stochastic Oscillator
- CRVS 55.47
- PKE 64.72
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.